Testing effectiveness (Phase 2)Study completedNCT01266447
What this trial is testing
Veliparib, Topotecan Hydrochloride, and Filgrastim or Pegfilgrastim in Treating Patients With Persistent or Recurrent Cervical Cancer
Who this might be right for
Cervical AdenocarcinomaCervical Adenosquamous CarcinomaCervical Small Cell Carcinoma+5 more
National Cancer Institute (NCI) 27